Cymbalta

Pharmaceuticals are ubiquitous contaminants in aquatic ecosystems. Adaptive monitoring, assessment, and management programs will… Expand

To the Editor: Serotonin syndrome [1,2] is caused by stimulation of a subset of serotonin receptors in the brainstem and spinal… Expand

Many patients with generalized anxiety disorder (GAD) do not receive adequate treatment. Several classes of drugs, including… Expand

Generalized anxiety disorder (GAD) has a lifetime prevalence in the US population of about 5.7%. Typically, GAD begins in early… Expand

Milnacipran (Savella) inhibits both norepinephrine and serotonin reuptake and is distinguished by a nearly 3-fold greater potency… Expand

effects of fibromyalgia on cognition. Specific pharmacologic treatment recommendations were given by Daniel J. Clauw, M.D., while… Expand

Abstract:  “Burning mouth syndrome” (BMS) refers to a chronic orofacial pain disorder usually unaccompanied by mucosal lesions or… Expand

Duloxetine (Cymbalta) is manufactured by Eli Lilly and Company and is the newest antidepressant to be approved by the Food and… Expand

A selective serotonin and norepinephrine reuptake inhibitor approved for depression and now also for diabetic peripheral… Expand

A series of naphthalenyloxy-arylpropylamines have been prepared and are demonstrated to be inhibitors of both serotonin and… Expand